Skip to main content
. 2020 May;8(9):605. doi: 10.21037/atm.2020.03.122

Table 1. Demographic characteristics of patients infected with CRKP.

Characteristics No./Total (%)
Female 85/252 (33.73)
Age, median (interquartile range), years 59 [50~73]
   0–4 5/252 (1.98)
   5–17 4/252 (1.59)
   18–49 55/252 (21.83)
   50–64 72/252 (28.57)
   65–79 91/252 (36.11)
   ≥80 25/252 (9.92)
Travel history to Southeast Asia 1/252 (0.4)
Health care exposure during the prior year
   Acute care hospitalization 17/252 (6.75)
   A resident of a long-term care facility 3/252 (1.20)
   The long-term acute care facility 2/252 (0.79)
Underlying conditions
   Charlson Comorbidity Index, median (interquartile range) 1 (0~2)
   None 128/252 (50.79)
   Cancer 10/252 (4.0)
   Diabetes mellitus 43/252 (17.06)
   Heart diseases 18/252 (7.14)
   Hypertension 108/252 (42.86)
   Immunodeficiency 0/252 (0.00)
   ICU stay 75/252 (29.76)
   Liver diseases 6/252 (2.38)
   Neurological diseases 66/252 (26.19)
   Pulmonary diseases 59/252 (23.41)
   Renal diseases 7/252 (2.78)
   Receipt of corticosteroids 6/252 (2.38)
   Receipt of immunosuppressor 0/252 (0.00)
   Smoking history 30/252 (11.90)
Indwelling devices prior to culture
   Arterial cannula 6/252 (2.38)
   Central venous catheter 128/252 (50.79)
   Gastric tube 11/252 (4.36)
   Tracheal cannula 112/252 (44.44)
   Tracheotomy 77/252 (30.56)
   Urinary catheter 225/252 (89.29)
Antimicrobials use prior to the culture within 30 days
   None 28/252 (11.11)
   Single antimicrobial use 91/224 (40.63)
   Multiple antimicrobials use 133/224 (59.37)
   3rd or 4th generation cephalosporins use 112/224 (50.00)
   Carbapenems use 55/224 (24.55)

CRKP, carbapenem-resistant Klebsiella pneumoniae.